Australia vs Sudan: HIV/AIDS deaths averted by antiretroviral therapy
Australia
989.62 deaths
in 2022
Sudan
958.82 deaths
in 2024
Australia rank
74th
Sudan rank
75th
HIV/AIDS deaths averted by antiretroviral therapy over time
- Australia
- Sudan
How they compare
Australia currently reports 989.62 deaths against 958.82 deaths in Sudan, a difference of 30.8 deaths.
The two have swapped places 2 times across 33 shared years of data; in 1990 it was Sudan ahead.
Australia ranks 74th and Sudan ranks 75th of 157 countries.
Across the 4 decades both report, Australia averaged higher in 3 and Sudan in 1.
Head to head by decade
| Decade | Australia | Sudan | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 260.07 deaths | 0 deaths | 260.07 deaths | Australia |
| 2000s | 740.59 deaths | 104.25 deaths | 636.34 deaths | Australia |
| 2010s | 840.56 deaths | 556.8 deaths | 283.77 deaths | Australia |
| 2020s | 982.57 deaths | 1,089 deaths | 106.11 deaths | Sudan |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv/aids deaths averted by antiretroviral therapy, Australia or Sudan?
- Australia, at 989.62 deaths against 958.82 deaths in Sudan as of 2022.
- What is the difference in hiv/aids deaths averted by antiretroviral therapy between Australia and Sudan?
- 30.8 deaths, with Australia ahead.
- How many years of comparable data are there for Australia and Sudan?
- 33 years are reported by both, from 1990 to 2022.
- How do Australia and Sudan rank globally for hiv/aids deaths averted by antiretroviral therapy?
- Australia ranks 74th and Sudan ranks 75th of 157 countries.
- Where does this data come from?
- Joint United Nations Programme on HIV/AIDS (2026) – with minor processing by Our World in Data, published as HIV/AIDS deaths averted by antiretroviral therapy. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of deaths prevented as a direct result of Antiretroviral Therapy (ART) among people living with HIV. It is calculated by comparing the observed mortality rates in individuals receiving ART to the estimated mortality rates in the absence of such treatment. This is the central estimate.